Fig. 1From: Beta-hydroxy beta-methylbutyrate/arginine/glutamine (HMB/Arg/Gln) supplementation to improve the management of cachexia in patients with advanced lung cancer: an open-label, multicentre, randomised, controlled phase II trial (NOURISH)Abridged Patient-Generated Subjective Global Assessment. Taken from the Macmillan Durham Cachexia Pack, 2007 (Supplementary Appendix 1)Back to article page